C9041 — Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
C9041 is a HCPCS Level II code for injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg. It belongs to the Outpatient Prospective Payment System section. It was terminated on June 30, 2020 and is not valid on new claims.
This code has been terminated
CMS terminated C9041 on June 30, 2020. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for C9041
- Long descriptor
- Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg
- Short descriptor
- Inj, coagulation factor xa
- Added
- April 1, 2019
- Terminated
- June 30, 2020
- BETOS
- O1E
- Pricing indicator
- 53 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Statute.
Codes adjacent to C9041
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If C9041 is not quite right, the correct code is very often within a few positions of it.
- C9033Injection, fosnetupitant 235 mg and palonosetron 0.25 mgterminated
- C9034Injection, dexamethasone 9%, intraocular, 1 mcgterminated
- C9035Injection, aripiprazole lauroxil (aristada initio), 1 mgterminated
- C9036Injection, patisiran, 0.1 mgterminated
- C9037Injection, risperidone (perseris), 0.5 mgterminated
- C9038Injection, mogamulizumab-kpkc, 1 mgterminated
- C9039Injection, plazomicin, 5 mgterminated
- C9040Injection, fremanezumab-vfrm, 1mgterminated
- C9042Injection, bendamustine hcl (belrapzo), 1 mgterminated
- C9043Injection, levoleucovorin, 1 mgterminated
- C9044Injection, cemiplimab-rwlc, 1 mgterminated
- C9045Injection, moxetumomab pasudotox-tdfk, 0.01 mgterminated
- C9046Cocaine hydrochloride nasal solution (goprelto), 1 mg
- C9047Injection, caplacizumab-yhdp, 1 mg
- C9048Dexamethasone, lacrimal ophthalmic insert, 0.1 mgterminated
- C9049Injection, tagraxofusp-erzs, 10 mcgterminated
Questions about C9041
What is HCPCS code C9041?
C9041 is a HCPCS Level II code for injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg. It sits in the Outpatient Prospective Payment System section.
Does Medicare cover C9041?
The CMS HCPCS file marks C9041 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is C9041 still valid?
No. C9041 was terminated on June 30, 2020 and should not be used on new claims.